OCUL logo

Ocular Therapeutix, Inc. (OCUL) Selling, General & Administrative Expenses

Annual SG&A:

$102.24M+$27.75M(+37.26%)
December 31, 2024

Summary

  • As of today, OCUL annual SG&A is $102.24 million, with the most recent change of +$27.75 million (+37.26%) on December 31, 2024.
  • During the last 3 years, OCUL annual SG&A has risen by +$35.17 million (+52.44%).
  • OCUL annual SG&A is now at all-time high.

Performance

OCUL SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULincome statement metrics

Quarterly SG&A:

$29.11M+$1.03M(+3.69%)
September 30, 2025

Summary

  • As of today, OCUL quarterly SG&A is $29.11 million, with the most recent change of +$1.03 million (+3.69%) on September 30, 2025.
  • Over the past year, OCUL quarterly SG&A has increased by +$6.30 million (+27.63%).
  • OCUL quarterly SG&A is now -4.54% below its all-time high of $30.50 million, reached on March 31, 2025.

Performance

OCUL Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULincome statement metrics

TTM SG&A:

-$3.96B-$249.67M(-6.73%)
September 30, 2025

Summary

  • As of today, OCUL TTM SG&A is -$3.96 billion, with the most recent change of -$249.67 million (-6.73%) on September 30, 2025.
  • Over the past year, OCUL TTM SG&A has dropped by -$4.06 billion (-4311.13%).
  • OCUL TTM SG&A is now -6417.84% below its all-time high of -$60.78 million.

Performance

OCUL TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

OCUL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+37.3%+27.6%-4311.1%
3Y3 Years+52.4%+55.5%-5764.7%
5Y5 Years+119.3%+133.2%-8221.6%

OCUL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+52.4%-4.5%+68.6%-73.6%at low
5Y5-Yearat high+119.3%-4.5%+133.2%-135.2%at low
All-TimeAll-Timeat high+4691.1%-4.5%+4980.3%-6417.8%at low

OCUL Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$29.11M(+3.7%)
$113.12M(+5.9%)
Jun 2025
-
$28.07M(-7.9%)
$106.82M(-1.5%)
Mar 2025
-
$30.50M(+19.9%)
$108.41M(+6.0%)
Dec 2024
$102.24M(+37.3%)
$25.44M(+11.5%)
$102.24M(+8.7%)
Sep 2024
-
$22.81M(-23.1%)
$94.07M(+5.5%)
Jun 2024
-
$29.66M(+21.9%)
$89.16M(+13.1%)
Mar 2024
-
$24.33M(+40.9%)
$78.86M(+5.9%)
Dec 2023
$74.49M(+3.2%)
$17.27M(-3.5%)
$74.49M(-2.1%)
Sep 2023
-
$17.90M(-7.5%)
$76.10M(-1.1%)
Jun 2023
-
$19.36M(-3.0%)
$76.92M(+1.9%)
Mar 2023
-
$19.96M(+5.7%)
$75.49M(+4.6%)
Dec 2022
$72.15M(+7.6%)
$18.88M(+0.9%)
$72.14M(+3.2%)
Sep 2022
-
$18.72M(+4.4%)
$69.93M(+1.5%)
Jun 2022
-
$17.93M(+7.9%)
$68.87M(+1.4%)
Mar 2022
-
$16.62M(-0.3%)
$67.94M(+1.3%)
Dec 2021
$67.07M(+35.6%)
$16.67M(-5.6%)
$67.07M(+5.1%)
Sep 2021
-
$17.65M(+3.9%)
$63.79M(+8.8%)
Jun 2021
-
$16.99M(+7.9%)
$58.61M(+10.8%)
Mar 2021
-
$15.75M(+17.7%)
$52.92M(+7.0%)
Dec 2020
$49.47M(+6.1%)
$13.39M(+7.3%)
$49.47M(+1.4%)
Sep 2020
-
$12.48M(+10.5%)
$48.78M(-0.9%)
Jun 2020
-
$11.30M(-8.2%)
$49.23M(-2.0%)
Mar 2020
-
$12.31M(-3.0%)
$50.21M(+7.7%)
Dec 2019
$46.61M
$12.69M(-1.8%)
$46.61M(+12.8%)
Sep 2019
-
$12.93M(+5.3%)
$41.33M(+21.9%)
DateAnnualQuarterlyTTM
Jun 2019
-
$12.28M(+41.1%)
$33.91M(+25.9%)
Mar 2019
-
$8.71M(+17.4%)
$26.95M(+13.6%)
Dec 2018
$23.73M(-27.0%)
$7.41M(+34.4%)
$23.73M(+10.4%)
Sep 2018
-
$5.51M(+3.8%)
$21.50M(-8.3%)
Jun 2018
-
$5.31M(-3.2%)
$23.45M(-18.3%)
Mar 2018
-
$5.49M(+5.9%)
$28.69M(-11.7%)
Dec 2017
$32.51M(+83.6%)
$5.18M(-30.6%)
$32.51M(-1.1%)
Sep 2017
-
$7.47M(-29.3%)
$32.85M(+12.1%)
Jun 2017
-
$10.56M(+13.5%)
$29.30M(+26.2%)
Mar 2017
-
$9.30M(+68.3%)
$23.21M(+31.1%)
Dec 2016
$17.70M(+36.0%)
$5.53M(+41.1%)
$17.70M(+11.3%)
Sep 2016
-
$3.92M(-12.3%)
$15.91M(+4.4%)
Jun 2016
-
$4.46M(+17.7%)
$15.24M(+8.5%)
Mar 2016
-
$3.79M(+1.7%)
$14.05M(+7.9%)
Dec 2015
$13.02M(+46.3%)
$3.73M(+14.9%)
$13.02M(+7.1%)
Sep 2015
-
$3.25M(-0.7%)
$12.16M(+7.5%)
Jun 2015
-
$3.27M(+18.3%)
$11.31M(+15.8%)
Mar 2015
-
$2.76M(-3.8%)
$9.77M(+9.9%)
Dec 2014
$8.89M(+272.8%)
$2.87M(+19.5%)
$8.89M(+47.7%)
Sep 2014
-
$2.40M(+38.9%)
$6.02M(+66.5%)
Jun 2014
-
$1.73M(-8.2%)
$3.62M(+46.4%)
Mar 2014
-
$1.89M(+222.2%)
$2.47M(+113.3%)
Dec 2013
$2.39M(+11.8%)
-
-
Jun 2013
-
$585.00K(+2.1%)
$1.16M(+102.1%)
Mar 2013
-
$573.00K
$573.00K
Dec 2012
$2.13M
-
-

FAQ

  • What is Ocular Therapeutix, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. annual SG&A year-on-year change?
  • What is Ocular Therapeutix, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. quarterly SG&A year-on-year change?
  • What is Ocular Therapeutix, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. TTM SG&A year-on-year change?

What is Ocular Therapeutix, Inc. annual SG&A?

The current annual SG&A of OCUL is $102.24M

What is the all-time high annual SG&A for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high annual SG&A is $102.24M

What is Ocular Therapeutix, Inc. annual SG&A year-on-year change?

Over the past year, OCUL annual SG&A has changed by +$27.75M (+37.26%)

What is Ocular Therapeutix, Inc. quarterly SG&A?

The current quarterly SG&A of OCUL is $29.11M

What is the all-time high quarterly SG&A for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high quarterly SG&A is $30.50M

What is Ocular Therapeutix, Inc. quarterly SG&A year-on-year change?

Over the past year, OCUL quarterly SG&A has changed by +$6.30M (+27.63%)

What is Ocular Therapeutix, Inc. TTM SG&A?

The current TTM SG&A of OCUL is -$3.96B

What is the all-time high TTM SG&A for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high TTM SG&A is -$60.78M

What is Ocular Therapeutix, Inc. TTM SG&A year-on-year change?

Over the past year, OCUL TTM SG&A has changed by -$4.06B (-4311.13%)
On this page